ALPHACENTRIC ADVISORS LLC – Celldex Therapeutics, Inc. Transaction History
ALPHACENTRIC ADVISORS LLC portfolio value:
$478,000
portfolio value
ALPHACENTRIC ADVISORS LLC quarter portfolio value change:
-27.74%
quarter
Celldex Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -179K | $28.11 | 17K | |
| Q4 2021 | share | 0.00% | 0 shares | -261K | $38.9 | 17K | |
| Q3 2021 | share | Decrease | -32.00% | -8K shares | 82K | $53.99 | 17K |
| Q2 2021 | share | 0.00% | 0 shares | 321K | $33.44 | 25K | |
| Q1 2021 | share | Increase | +614.29% | 21.5K shares | 454K | $20.6 | 25K |
| Q4 2020 | share | 0.00% | 0 shares | 9K | $17.52 | 3.5K | |
| Q3 2020 | share | Increase | 0.00% | 3.5K shares | 52K | $14.83 | 3.5K |